Literature DB >> 3571584

Detection of bronchial abnormalities: comparison of CT and bronchoscopy.

C I Henschke, S D Davis, Y Auh, P Romano, J Westcott, Y M Berkmen, E Kazam.   

Abstract

We evaluated the usefulness of CT as compared with both visual and pathologic findings from fiberoptic bronchoscopy (FOB) in detecting bronchial lesions in 100 consecutive patients undergoing both procedures. There was agreement between CT and visual FOB in 83% of cases and CT and pathologic FOB in 68%. In the malignant disease category CT detected bronchial abnormalities in 59% (27 of 46) as compared with 57% (26 of 46) by visual FOB; both agreed in 81% of the cases (37 of 46). On the basis of CT findings alone, we retrospectively divided the cases into those for which we expected FOB to have high diagnostic yield (peribronchial abnormalities, n = 49) and a low diagnostic yield (i.e., no bronchial abnormality, n = 51). For the malignant disease category, selection by CT findings resulted in successful diagnosis by FOB in 69% for the high yield group as compared with 29% for the low yield group. We conclude that CT has excellent correlation with visual and pathologic results of FOB in detecting bronchial abnormalities and that CT, when used as an initial screening test, can enhance the yield by allowing appropriate selection of patients.

Entities:  

Mesh:

Year:  1987        PMID: 3571584     DOI: 10.1097/00004728-198705000-00012

Source DB:  PubMed          Journal:  J Comput Assist Tomogr        ISSN: 0363-8715            Impact factor:   1.826


  8 in total

1.  Guidelines for radiologically guided lung biopsy.

Authors:  A Manhire; M Charig; C Clelland; F Gleeson; R Miller; H Moss; K Pointon; C Richardson; E Sawicka
Journal:  Thorax       Date:  2003-11       Impact factor: 9.139

Review 2.  Computed tomography of the airways.

Authors:  S A Worthy; C D Flower
Journal:  Eur Radiol       Date:  1996       Impact factor: 5.315

Review 3.  The Society for Translational Medicine: indications and methods of percutaneous transthoracic needle biopsy for diagnosis of lung cancer.

Authors:  Qinghua Zhou; Jingsi Dong; Jie He; Deruo Liu; David H Tian; Shugeng Gao; Shanqing Li; Lunxu Liu; Jianxing He; Yunchao Huang; Shidong Xu; Weimin Mao; Qunyou Tan; Chun Chen; Xiaofei Li; Zhu Zhang; Gening Jiang; Lin Xu; Lanjun Zhang; Jianhua Fu; Hui Li; Qun Wang; Lijie Tan; Danqing Li; Qinghua Zhou; Xiangning Fu; Zhongmin Jiang; Haiquan Chen; Wentao Fang; Xun Zhang; Yin Li; Ti Tong; Zhentao Yu; Yongyu Liu; Xiuyi Zhi; Tiansheng Yan; Xingyi Zhang; Roberto F Casal; Eugenio Pompeo; Angelo Carretta; Marc Riquet; Ottavio Rena; Pierre-Emmanuel Falcoz; Hisashi Saji; Ali Zamir Khan; Jose Luis Danguilan; Diego Gonzalez-Rivas; Nicolas Guibert; Chengchu Zhu; Jianfei Shen
Journal:  J Thorac Dis       Date:  2018-09       Impact factor: 2.895

4.  Role of computed tomographic scanning of the thorax prior to bronchoscopy in the investigation of suspected lung cancer.

Authors:  C Laroche; I Fairbairn; H Moss; J Pepke-Zaba; L Sharples; C Flower; R Coulden
Journal:  Thorax       Date:  2000-05       Impact factor: 9.139

Review 5.  Decision making in patients with pulmonary nodules.

Authors:  David E Ost; Michael K Gould
Journal:  Am J Respir Crit Care Med       Date:  2011-10-06       Impact factor: 21.405

6.  Evidence based imaging strategies for solitary pulmonary nodule.

Authors:  Yi-Xiang J Wang; Jing-Shan Gong; Kenji Suzuki; Sameh K Morcos
Journal:  J Thorac Dis       Date:  2014-07       Impact factor: 2.895

7.  Usefulness of FDG PET/CT in determining benign from malignant endobronchial obstruction.

Authors:  Arthur Cho; Jin Hur; Won Jun Kang; Ho Jin Cho; Jae-Hoon Lee; Mijin Yun; Jong Doo Lee
Journal:  Eur Radiol       Date:  2010-11-27       Impact factor: 5.315

8.  Virtual endoscopy of the tracheo-bronchial system: sub-millimeter collimation with the 16-row multidetector scanner.

Authors:  M Fawad Khan; Christopher Herzog; Hanns Ackermann; Thomas O F Wagner; Adel Maataoui; Marc Harth; Nasreddin D Abolmaali; Volkmar Jacobi; Thomas J Vogl
Journal:  Eur Radiol       Date:  2004-05-07       Impact factor: 5.315

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.